ScholarIQanswers from OpenAlex

The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation

PaperCitations, authors & open-access status

The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation have?

ScholarIQcitation count

The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation has 125 citations in the OpenAlex counts ScholarIQ stores.

When was The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation published?

ScholarIQyear

The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation has 2010 year in the ScholarIQ index.

What is the open-access status of The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation?

ScholarIQoa status

The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation has closed oa status in the ScholarIQ index.

What is the DOI of The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation?

ScholarIQdoi

The DOI for The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation is on the source record.

What is the PMID of The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation?

ScholarIQpmid

The PMID for The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation is on the source record.

What is the OpenAlex record for The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation?

ScholarIQopenalex

The OpenAlex for The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial